Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Neurodevelopmental Outcomes in Children With Congenital Heart Disease Evaluation and Management A Scientific Statement From the American Heart Association

Neurodevelopmental Outcomes in Children With Congenital Heart Disease Evaluation and Management... AHA Scientific Statement Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management A Scientific Statement From the American Heart Association This statement has been approved by the American Academy of Pediatrics. Bradley S. Marino, MD, MPP, MSCE, FAHA, Co-Chair; Paul H. Lipkin, MD; Jane W. Newburger, MD, MPH, FAHA; Georgina Peacock, MD, MPH; Marsha Gerdes, PhD; J. William Gaynor, MD; Kathleen A. Mussatto, PhD, RN; Karen Uzark, PhD, CNP, FAHA; Caren S. Goldberg, MD, MS; Walter H. Johnson, Jr, MD; Jennifer Li, MD; Sabrina E. Smith, MD, PhD; David C. Bellinger, PhD; William T. Mahle, MD, FAHA, Co-Chair; on behalf of the American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council Background—The goal of this statement was to review the available literature on surveillance, screening, evaluation, and management strategies and put forward a scientific statement that would comprehensively review the literature and create recommendations to optimize neurodevelopmental outcome in the pediatric congenital heart disease (CHD) population. Methods and Results—A writing group appointed by the American Heart Association and American Academy of Pediatrics reviewed the available literature addressing developmental disorder and disability and developmental http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation Wolters Kluwer Health

Neurodevelopmental Outcomes in Children With Congenital Heart Disease Evaluation and Management A Scientific Statement From the American Heart Association

Mahle, William T.
Circulation , Volume 126 (9) – Aug 1, 2012
Download PDF
30 pages

Loading next page...
 
/lp/wolters-kluwer-health/neurodevelopmental-outcomes-in-children-with-congenital-heart-disease-8PwltYYzQj

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 2012 American Heart Association, Inc.
ISSN
0009-7322
eISSN
1524-4539
DOI
10.1161/CIR.0b013e318265ee8a
pmid
22851541
Publisher site
See Article on Publisher Site

Abstract

AHA Scientific Statement Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management A Scientific Statement From the American Heart Association This statement has been approved by the American Academy of Pediatrics. Bradley S. Marino, MD, MPP, MSCE, FAHA, Co-Chair; Paul H. Lipkin, MD; Jane W. Newburger, MD, MPH, FAHA; Georgina Peacock, MD, MPH; Marsha Gerdes, PhD; J. William Gaynor, MD; Kathleen A. Mussatto, PhD, RN; Karen Uzark, PhD, CNP, FAHA; Caren S. Goldberg, MD, MS; Walter H. Johnson, Jr, MD; Jennifer Li, MD; Sabrina E. Smith, MD, PhD; David C. Bellinger, PhD; William T. Mahle, MD, FAHA, Co-Chair; on behalf of the American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council Background—The goal of this statement was to review the available literature on surveillance, screening, evaluation, and management strategies and put forward a scientific statement that would comprehensively review the literature and create recommendations to optimize neurodevelopmental outcome in the pediatric congenital heart disease (CHD) population. Methods and Results—A writing group appointed by the American Heart Association and American Academy of Pediatrics reviewed the available literature addressing developmental disorder and disability and developmental

Journal

Circulation – Wolters Kluwer Health

Published: Aug 1, 2012

There are no references for this article.